Beat is a senior commercial strategist with more than 20 years of experience in the pharmaceutical industry. He has held numerous leadership positions in both Switzerland and the US, gaining a deep understanding of the cross-functional needs of global lifecycle teams, local brand teams and biotech companies. Throughout his career, Beat developed forward-looking commercial strategies for medicines from the earliest clinical development stages to the end of their lifecycle and led the global or local launch of 10 blockbuster drugs.

The majority of his career Beat has focused on Oncology and Hematology. At AstraZeneca he led the global commercial Immuno-Oncology Lung Cancer teams and successfully built up the cross-functional teams in Switzerland as Business Unit Director Oncology. At Roche he managed the Swiss Avastin and Hematology Franchises and worked in various global Lifecycle Teams in project management and marketing roles.

Beat studied Chemistry at the Swiss Federal Institute of Technology (ETH) in Zurich, where he also earned his PhD. He continued his academic research with postdoctoral studies in biopharmaceutical chemistry at The Scripps Research Institute in La Jolla, California. More recently, Beat completed the Accelerated Development Program for executives at the London Business School.